Pyxis Oncology (PYXS) Cash & Equivalents: 2024-2025
Historic Cash & Equivalents for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $8.9 million.
- Pyxis Oncology's Cash & Equivalents fell 26.02% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 26.02%. This contributed to the annual value of $19.5 million for FY2024, which is N/A change from last year.
- Pyxis Oncology's Cash & Equivalents amounted to $8.9 million in Q3 2025, which was down 16.90% from $10.7 million recorded in Q2 2025.
- In the past 5 years, Pyxis Oncology's Cash & Equivalents ranged from a high of $28.0 million in Q1 2024 and a low of $8.9 million during Q3 2025.
- Its 2-year average for Cash & Equivalents is $16.7 million, with a median of $12.8 million in 2025.
- Data for Pyxis Oncology's Cash & Equivalents shows a maximum YoY slumped of 57.19% (in 2025) over the last 5 years.
- Pyxis Oncology's Cash & Equivalents (Quarterly) stood at $19.5 million in 2024, then fell by 26.02% to $8.9 million in 2025.
- Its Cash & Equivalents stands at $8.9 million for Q3 2025, versus $10.7 million for Q2 2025 and $12.8 million for Q1 2025.